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Research
Correspondence Percutaneous Coronary Intervention After ST-Segment
Elevation Myocardial Infarction in Nonagenarians
Use Rates and In-Hospital MortalityTo the Editor: A 2007 American Heart Association panel concluded
hat, despite growing numbers, there remains a lack of data on the
utcomes of percutaneous coronary intervention (PCI) after ST-segment
levationmyocardial infarction (STEMI) in very elderly patients (1). The
oal of this study was to determine national rates of use and in-hospital
ortality of PCI after STEMI in patients 90 years old.
We conducted a cross-sectional analysis of 2004 to 2008 hospital
ischarge information from the Healthcare Cost and Utilization
roject Nationwide Inpatient Sample (HCUP-NIS), a 20% stratified
ample of acute hospital admissions. Sampling weights were used to
enerate national estimates. We selected all patients90 years old in
CUP-NIS between 2004 and 2008 who were nonelectively admit-
ed with a primary diagnosis of STEMI. Patients not presenting for
nitial care of a new infarction (410.x2) were excluded. Admissions
issing mortality data (0.1%) were excluded. Percutaneous coro-
ary intervention was indicated with primary procedure codes of
6.01-36.07 or 00.66. Comorbidity was measured with the age-
ndependent Charlson Comorbidity Index and grouped into mild (0
o 1), moderate (2 to 4), and severe (5) (2). We calculated rates of use
nd in-hospital mortality. A stepwise logistic multiple regression model
as created for in-hospitalmortality.Data analysis andmanagementwere
erformed with SAS (version 9.2; SAS Institute, Cary, North Carolina).
his study was exempted by the Institutional Review Board of Georgia
ealth Sciences University, because HCUP-NIS is a public database
ith no personal identifying information.
Over the 5 years, there were 33,644 admissions for STEMI in
hose90 years old. Mean age was 92.64 years (SEM 0.03; range 90
o 111), and most were female (71.3%). Of the patients, 19.3% had
ild comorbidities, 70.5% had moderate comorbidities, and 10.2%
ad severe comorbidities. The overall use rate of PCI was 16.9%, with
CI more likely to occur in men, those with mild comorbidity, and at
arge, urban, and teaching hospitals (Table 1). The rate of PCI use
mong nonagenarians more than doubled during the study period.
he overall mortality rate among those 90 years old was 24.6%. A
omparison of overall mortality between 2004/2005 (early) and
007/2008 (late) showed a significant lower mortality over time
25.5% vs. 24.1%, p  0.001). Patients who received PCI had a
significantly lower mortality rate than those who did not receive PCI
(15.1% vs. 26.5%) (p  0.001). On multivariate analysis, PCI
continued to be associated with less mortality (odds ratio: 0.47, 95%
CI: 0.44 to 0.51) even after adjustment for demographic data,
comorbidity, and hospital characteristics.
This is the first national analysis of use and in-hospital mortality of
PCI after STEMI for patients90 years of age. The rate of PCI for
STEMIs in nonagenarians more than doubled between 2004 and
2008, with approximately 1 in 4 patients 90 years with STEMIs
receiving PCI in 2008. The overall mortality rate was 24.6% and was
significantly lower among patients receiving PCI relative to those notreceiving a PCI (15.1% vs. 26.5%), even after multivariate adjustment
for other explanatory variables (odds ratio: 0.47).
Our analysis significantly expands upon prior limited single-center
studies in nonagenarians. A single-center analysis of 24 nonagenarians
showed a PCI use rate of 54% and an associated mortality of 23%
versus 36% in the non-PCI group (3). In another study of 54
nonagenarians with STEMIs, 59% received PCI with an in-hospital
mortality of 11% (4). A Denmark study among 109 nonagenarians
undergoing PCI after STEMI showed a 30-day mortality of 25.8%,
a 1-year mortality of 32.5%, and a 5-year mortality of 57.3% (5).
This study has several limitations. Because HCUP-NIS is an
administrative database, some clinical characteristics—including time
to presentation, primary versus delayed PCI, and co-existence of left
bundle branch block on electrocardiogram—were missing. Although
we are unable to absolutely exclude selection bias, the decrease in
mortality between 2004 and 2008, despite a less rigorously selected
PCI cohort (the proportion of patients receiving PCI almost doubled
between 2004 and 2008), provides support for a real treatment effect
not based on selection bias. It remains possible, however, that changes
in other processes of care not captured in our analysis might have
contributed to the gains in mortality observed. Errors in ICD-9
coding and documentation are possible, although the error rate has
been found to be low in this database. Lastly, data for each patient was
limited to a single hospital stay; we do not have information on
post-hospital events or outcomes such as readmission or long-term
survival, although the high mortality rates in STEMIs make even
short-term gains clinically relevant.
In the setting of limited prior data, the use rate of PCI in
nonagenarians more than doubled between 2004 and 2008. This
study reports use rates and in-hospital mortality of PCI after
STEMI in 33,644 nonagenarians. Percutaneous coronary inter-
vention was associated with a significantly lower in-hospital
mortality even after adjustment for other explanatory variables
and might benefit a large proportion of nonagenarians who
present with a STEMI, although further study is needed. Risk
stratification and long-term outcomes of PCI versus non-PCI
therapy in the setting of STEMIs are important areas of future
research.
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